Valuation: Nipro Corporation

Market Cap 225B 1.42B 1.27B 1.18B 1.06B 1.99B 136B 2.02B 14.03B 5.6B 70.93B 5.34B 5.23B P/E 2027 *
13.9x
P/E 2028 * 10.6x
Enterprise Value 724B 4.58B 4.11B 3.79B 3.43B 6.41B 437B 6.51B 45.2B 18.03B 228B 17.21B 16.84B EV / Sales 2027 *
1.04x
EV / Sales 2028 * 0.97x
Free-Float
85.55%
Yield 2027 *
2.55%
Yield 2028 * 3.53%
1 day+1.05%
1 week+0.37%
Current month-1.24%
1 month-5.82%
3 months-16.93%
6 months-11.87%
Current year-8.50%
1 week 1,331
Extreme 1331
1,371
1 month 1,292.5
Extreme 1292.5
1,389
Current year 1,292.5
Extreme 1292.5
1,760.5
1 year 1,292.5
Extreme 1292.5
1,760.5
3 years 1,070.5
Extreme 1070.5
1,760.5
5 years 987
Extreme 987
1,760.5
10 years 908
Extreme 908
1,760.5
Manager TitleAgeSince
Director of Finance/CFO 58 01/06/2025
President 58 01/06/2025
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 81 26/06/2025
Director/Board Member 54 01/06/2009
Director/Board Member 58 01/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%+0.37%-12.01%+19.07% 1.41B
+1.88%+4.04%-17.41%+12.62% 178B
+2.55%+4.75%-17.07%+19.03% 117B
+2.46%+4.39%+4.16%+39.87% 116B
+0.28%+2.53%-43.87%+6.06% 91.03B
+1.91%-2.91%-1.52%+76.15% 61.89B
-0.32%-0.66%+10.51%+81.65% 55.85B
+1.63%+2.06%+7.67%-21.17% 53.16B
+2.32%+4.07%-9.20%+47.17% 44.35B
+1.94%+5.08%-1.18%-6.94% 33.59B
Average +1.55%+0.79%-7.99%+27.35% 75.15B
Weighted average by Cap. +1.70%+1.25%-10.85%+26.18%

Financials

2027 *2028 *
Net sales 699B 4.43B 3.97B 3.66B 3.31B 6.19B 422B 6.29B 43.66B 17.42B 221B 16.62B 16.26B 727B 4.6B 4.12B 3.8B 3.44B 6.44B 438B 6.54B 45.39B 18.11B 229B 17.28B 16.91B
Net income 15.64B 99.08M 88.75M 81.88M 74.09M 139M 9.44B 141M 977M 390M 4.94B 372M 364M 20.5B 130M 116M 107M 97.09M 182M 12.36B 184M 1.28B 511M 6.47B 487M 477M
Net Debt 499B 3.16B 2.83B 2.61B 2.36B 4.42B 301B 4.49B 31.17B 12.44B 158B 11.87B 11.61B 481B 3.05B 2.73B 2.52B 2.28B 4.26B 290B 4.33B 30.04B 11.99B 152B 11.44B 11.19B
Projected Income Statement - Annual - Nipro Corporation
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
Date Price Change Volume
29/10/26 JP¥1,351.50 +1.05% 1,440,900
28/10/26 JP¥1,337.50 -1.58% 579,700
27/10/26 JP¥1,359.00 +0.67% 561,500
26/10/26 JP¥1,350.00 +0.48% 507,400
23/10/26 JP¥1,343.50 +0.22% 583,400
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Nipro Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,351.50JPY
Average target price
1,956.00JPY
Spread / Average Target
+44.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Nipro Corporation
  1. Stock Market
  2. Stocks
  3. 8086 Stock